Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19…

","datePublished":"2021-03-19T16:15:00.0000000+00:00","image":"https://www.who.int/images/default-source/campaigns/vaccine-safety/world_health_organization_executive_board_room.jpg?sfvrsn=acb70800_17","publisher":{"@type":"Organization","name":"World Health Organization: WHO","logo":{"@type":"ImageObject","url":"https://www.who.int/Images/SchemaOrg/schemaOrgLogo.jpg","width":250,"height":60}},"dateModified":"2021-03-19T16:15:00.0000000+00:00","mainEntityOfPage":"https://www.who.int/news/item/19-03-2021-statement-of-the-who-global-advisory-committee-on-vaccine-safety-(gacvs)-covid-19-subcommittee-on-safety-signals-related-to-the-astrazeneca-covid-19-vaccine","@context":"http://schema.org","@type":"NewsArticle"};

Continue reading here:

Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19...

Related Posts
Tags: